CSIMarket
 


Hutchmed china Limited  (HCM)
Other Ticker:  
 

Cumulative Hutchmed China Limited's Leverage Ratio for Trailing Twelve Months Period

HCM's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

HCM Leverage Ratio for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth 16.73 % 16.73 % 16.73 % 16.73 % -38.73 %
Y / Y Total Liabilities Growth 31.06 % 31.06 % 31.06 % 31.06 % 8.63 %
Leverage Ratio for Trailing Twelve Months Period 0.74 0.72 0.7 0.68 0.66
Total Ranking # 802 # # # # 1536
Seq. Equity Growth 0 % 0 % 0 % 16.73 % 0 %
Seq. Total Liabilities Growth 0 % 0 % 0 % 31.06 % 0 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Despite debt repayement of 0% in IV. Quarter, Leverage Ratio for Trailing Twelve Months Period improved to 0.74, above Hutchmed China Limited's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 114 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Hutchmed China Limited. While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are HCM's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 115
Sector # 243
S&P 500 # 818


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.72 0.4 0.25
(Dec 31 2023)   0




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Durect Corp  2.03 
Arcutis Biotherapeutics Inc   2.02 
Zoetis Inc   2.01 
Biolinerx Ltd   1.96 
Maravai Lifesciences Holdings Inc   1.96 
Jazz Pharmaceuticals Plc  1.95 
Rockwell Medical inc   1.90 
Vbi Vaccines Inc  1.87 
Paxmedica Inc   1.86 
Nls Pharmaceutics Ltd   1.83 
Oncorus Inc   1.79 
Mustang Bio inc   1.78 
Tg Therapeutics Inc   1.76 
Gri Bio Inc   1.72 
Abeona Therapeutics Inc   1.72 
Ibio inc   1.71 
Axsome Therapeutics Inc   1.69 
Veru Inc   1.69 
Marinus Pharmaceuticals Inc   1.68 
Janone Inc   1.67 
Biofrontera Inc   1.66 
Tempest Therapeutics Inc   1.65 
Rvl Pharmaceuticals Plc  1.62 
Grifols Sa  1.55 
Societal Cdmo Inc   1.54 
Capricor Therapeutics inc   1.53 
Timber Pharmaceuticals Inc   1.53 
Abvc Biopharma Inc   1.52 
Reviva Pharmaceuticals Holdings Inc   1.52 
Emergent Biosolutions Inc   1.50 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com